Evoke Pharma
EVOK
$0.45
Share price
2.27%
Change (1 day)
-76.68%
Change (1 year)
Categories
Operating Margin for Evoke Pharma (EVOK)
Operating Margin as of May 2024 (TTM): -307.90%
According to Evoke Pharma 's latest financial reports and stock price the company's current Operating Margin is -307.90%. At the end of 2021 the company had an Operating Margin of -527.66%.
Operating Margin history for Evoke Pharma from 2021 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -527.66% | -99.08% |
| 2020 | -57,144.53% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 ANI Pharmaceuticals ANIP | -9.64% | -96.87% | 🇺🇸 USA |
 Amphastar Pharmaceuticals AMPH | 24.29% | -107.89% | 🇺🇸 USA |
 Aerie Pharmaceuticals AERI | -10.86% | -96.47% | 🇺🇸 USA |
 Ironwood Pharmaceuticals
IRWD | 62.76% | -120.38% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.